EVCA Healthcare Innovation Series Dinner @ ViVE
Fireside chat and dinner with healthcare leaders on clinical co-pilots, women's health, and clinical trials.
Speakers: Dr. Neel Shah MD., Eirini Schlosser, Dr. Rebecca Miksad, and Taylor McPartland
-Dr. Neel Shah, MD, MPP, FACOG, is Chief Medical Officer of Maven Clinic, the largest virtual clinic for women's and family health, and visiting scientist at Harvard Medical School. He is the co-founder of the March for Moms Association, a coalition of more than 20 leading organizations dedicated to increasing public and private investment in the wellbeing of mothers, and the founder of Costs of Care, an NGO that curates insights from clinicians and patients to help delivery systems provide better care. His work to build equitable, trustworthy systems of care is featured in the documentaries “Color of Care,” produced by Oprah Winfrey, and “Aftershock,” which is currently streaming on Hulu. Dr. Shah serves on the advisory board of the National Institutes of Health, Office of Women's Health Research.
-Eirini Schlosser is a serial tech entrepreneur with over a decade of experience in building NLP applications and leading teams in developing IP-heavy technologies. In addition to her years in M&A at Morgan Stanley and early foundation in biochemistry, she holds degrees from the Ohio State University and London Business school as well as professional certifications from MIT in machine learning and AI. Eirini is currently the Founder and CEO of Dyania Health, a fast-growing healthcare AI company that trained Synapsis AI, a medically specialized Large Language Model (LLM) to automatically read, understand, and deduce clinical conclusions from electronic medical records for use in clinical research, quality, and reporting with an accuracy of above 94%.
Eirini's mission has been to remove manual bottlenecks in healthcare and life sciences to empower clinicians to focus their time on treating patients. Synapsis AI has achieved this level of performance with a higher accuracy than individual human clinicians in studies at institutions such as Cleveland Clinic. Her multidisciplinary team includes seasoned leadership who joined from Flatiron Health, Amazon, BloombergAI, and McKinsey as well as prestigious institutions like NYU Langone, Memorial Sloan Kettering, and UCLA Health. Together they bridge the gap between medicine, engineering, and applied AI research. This unique blend of experiences is what powers Dyania Health on its mission to revolutionize the healthcare and life sciences industries.
- Dr. Rebecca Miksad is a mission-driven Physician-Scientist with extensive expertise in cancer and patient-centric health technology and AI solutions. As Chief Medical Officer at Color Health, she oversees Color’s medical and clinical functions, driving the expansion of cancer screening, diagnostics, care navigation, and survivorship tools for program participants. Dr. Miksad previously founded and led the Strategic Affairs team and Research Unit at Flatiron Health, developing pioneering healthtech products and establishing industry standards for real-world data. Her work has influenced FDA guidances and advanced Health Equity initiatives. With over 100 scientific publications, Dr. Miksad is an internationally recognized leader in oncology, clinical trials and data science. She established the first High Risk Cancer Genetics clinic at Boston Medical Center, where she is an Associate Professor and continues to care for patients. She previously directed the Gastrointestinal Cancer program at Beth Israel Deaconess Medical Center and conducted NIH-funded research. Clinically trained as a medical oncologist, Dr. Miksad holds an MD with Honors from Cornell University and an MPH in Clinical Effectiveness from Harvard University.
- Taylor, a native of Northern California, began his entrepreneurial journey by co-founding his first company in 2010, where he served as a leader for the following 6 years. Throughout this period, he developed a profound passion for harnessing innovation to tackle the systemic challenges our society faces on a daily basis. Motivated by this mission, Taylor established ScaleHealth in 2018 with a vision to create a global health transformation ecosystem that ensures universal access to cutting-edge healthcare solutions, promoting overall well-being. Since its inception, ScaleHealth has played a pivotal role in scaling startups worldwide while enabling health organizations and partners to significantly reduce their costs while increasing their impact.